Dysferlinopathy as an extrahepatic cause for the elevation of serum transaminases;Dysferlinopathie als extrahepatische ursache von transaminasenerhö hungen

Medizinische Klinik

Volumn 99, Issue 6, 2004, Pages 326-329

  Brüss, Michael ^a   Homann, Jürgen ^b   Molderings, Gerhard J ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Innere Abteilung   (Germany)

Author keywords

Distal myopathies; Dysferlinopathy; Transaminases

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CREATINE KINASE; METHOTREXATE; PREDNISONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; DYSFERLINOPATHY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MOLECULAR GENETICS; MUSCLE BIOPSY; MYOGRAPHY; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; TREATMENT OUTCOME;

EID: 3042623548     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-004-1046-1     Document Type: Article

References (21)

1. Anderson LV, Davison K, Moss JA, et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 1999;8:855-61.
2. Banasal D, Miyake K, Vogel SS, et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003;423:168-72.
3. Barohn RJ, Miller RG, Griggs RC. Autosomal recessive distal dystrophy. Neurology 1991;41:1365-70.
4. Bashir R, Britton S, Strachan T, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998;20:37-42.
5. Bittner RE, Anderson LV, Burkhardt E, et al. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet 1999;23:141-2.
6. Doherty KR, McNally EM. Repairing the tears: dysferlin in muscle membrane repair. Trends Mol Med 2003;9:327-30.
7. Emery AEH. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromuscul Disord 1991;1:19-29.
8. Fanin M, Angelini C. Muscle pathology in dysferlin deficiency. Neuropathol Appl Neurobiol 2002;28:461-70.
9. Fanin M, Pegoraro E, Matsuda-Asada C, et al. Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy. Neurology 2001;56:660-5.
10. Illa I. Distal myopathies. J Neurol 2000;247:169-74.
11. Illa I, Serrano-Munuera C, Gallardo E, et al. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 2001;49:130-4.
12. Lennon NJ, Kho A, Bacskai BJ, et al. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 2003;278:50466-73.
13. Liu J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998;20:31-6.
14. Mahjnek I, Marconi G, Bushby K, et al. Dysferlinopathy (LGMD2B): a 23 year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutation. Neuromuscul Disord 2001;11:20-6.
15. Matsumara T, Aoki M, Nagano A, et al. Molecular genetic analysis of dysferlin in Japanese patients with Miyoshi myopathy. Proc Jpn Acad 1999;75:207-12.
16. Nakagawa M, Matsuzaki T, Suehara M, et al. Phenotypic variation in a large Japanese family with Miyoshi myopathy with nonsense mutation in exon 19 of dysferlin gene. J Neurol Sci 2001;184:15-9.
17. Nigro V. Molecular bases of autosomal recessive limb-girdle muscular dystrophies. Acta Myol 2003;22:35-42.
18. Piccolo F, Moore SA, Ford GC, et al. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies. Ann Neurol 2000;48:902-12.
19. Tarnopolsky MA, Beal MF. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol 2001;49:561-74.
20. Thomas L. Labor und Diagnose, 5. Aufl. Frankfurt/Main: TH-Books, 2000.
21. Weiler T, Bashir R, Anderson LV, et al. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet 1999;8:871-7.